Anticancer Effects of Niclosamide in Human GlioblastomaAnja Wieland, Björn Scheffler, Martin Glas et al.|Clinical Cancer Research|2013Cited by 161
Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Björn Scheffler, Mihaela Keller et al.|Annals of Neurology|2010Cited by 132
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Martin Glas, Gerrit H. Gielen et al.|Journal of Translational Medicine|2019Cited by 78
Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in GlioblastomaMartin Glas, Björn Scheffler, Harald Neumann et al.|Stem Cells|2013Cited by 74
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human GlioblastomaRoman Reinartz, Björn Scheffler, Martin Glas et al.|Clinical Cancer Research|2016Cited by 72